
zzso zzso zzso given zzso zzso every 4 hours for three doses, has replaced zzso as standard zzso therapy for patients receiving zzso zzso Several clinical observations suggested that zzso may be effective when given in a single zzso zzso demonstration of efficacy over a wide dose range, zzso similar efficacy with dosing intervals of 2, 4, 6, and 8 hours, and zzso efficacy of zzso regimens with high-dose zzso and other zzso zzso In this study, patients receiving zzso chemotherapy were zzso to receive one of three zzso dosing zzso zzso zzso zzso IV every 4 hours zzso 3 zzso schedule), zzso 32 zzso IV zzso 1, or zzso 8 zzso IV zzso zzso All patients were chemotherapy zzso at least 18 years of age, zzso performance status zzso or zzso zzso and zzso The number of zzso episodes, zzso and food intake were measured during the 24 hours following zzso zzso Six hundred zzso zzso patients were zzso to the three zzso treatment zzso 301 received zzso zzso zzso to 70 zzso and 317 received high-dose zzso zzso or zzso 100 zzso Patients in both zzso groups receiving zzso 32 zzso had a higher complete response rate, lower failure rate, fewer total zzso episodes, less zzso and more food intake than did patients receiving zzso 8 zzso In addition, the zzso schedule was superior to the standard zzso schedule in that it had a lower failure rate and higher food intake and was equivalent to the standard regimen in all other zzso All three schedules were well zzso zzso 32 zzso given prior to zzso is superior to a single zzso dose and is at least as effective, if not superior to, the standard zzso schedule zzso zzso every 4 zzso On the basis of these data, zzso 32 zzso should be considered standard therapy in patients receiving zzso chemotherapy and should be the schedule with which new zzso and alternate dosing schedules are zzso 

